Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial

PHASE4RecruitingINTERVENTIONAL
Enrollment

900

Participants

Timeline

Start Date

February 6, 2023

Primary Completion Date

April 30, 2026

Study Completion Date

October 31, 2026

Conditions
SurgeryPain, Postoperative
Interventions
DRUG

NSAID

"Once randomized to this group the surgical team will elect for 1 of the following treatment options to be given:~* Ibuprofen 600 milligram (mg) by mouth every six hours as needed for pain (10 doses)~* Celecoxib 400 mg by mouth once then 200 mg every twelve hours as needed for pain (10 doses)~* Naproxen 500 mg by mouth once then 250 mg by mouth every eight hours as needed for pain (10 doses)"

DRUG

Opioid

"Once randomized to this group the surgical team will elect for 1 of the following treatment options to be given:~* Oxycodone 5 mg by mouth every four to six hours as needed for pain, 10 doses~* Morphine 7.5 mg by mouth every four to six hours as needed for pain, 10 doses~* Hydromorphone 2 mg by mouth every four to six hours as needed for pain, 10 doses"

DRUG

Acetaminophen

Acetaminophen 1000 mg by mouth every 6 hours around the clock for the first three days after surgery then as needed thereafter (20 doses).

Trial Locations (8)

19140

RECRUITING

Temple University - Temple Health, Philadelphia

27599

RECRUITING

University of North Carolina Hospitals, Chapel Hill

48109

RECRUITING

University of Michigan, Ann Arbor

48202

RECRUITING

Henry Ford Health System, Detroit

63130

RECRUITING

Washington University in Saint Louis, St Louis

08103

RECRUITING

Cooper University Health Care, Camden

M5S 1B2

RECRUITING

Women's College Hospital, Toronto

Unknown

RECRUITING

Unity Health Toronto, Toronto

All Listed Sponsors
collaborator

Patient-Centered Outcomes Research Institute

OTHER

lead

University of Michigan

OTHER